Yale University: Depression trials
The registry lists 51 Depression studies with Yale University as lead sponsor. 6 are open to participants now and 13 have results posted.
Early Phase 1 1Phase 1 5Phase 2 7Phase 3 4Phase 4 1No phase 34(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The Efficacy of Psilocybin Therapy for Depression in Parkinson's DiseaseRecruitingNCT07610369Phase 2
- Trial Phase: Syndemic Adapted Medly UgandaNot yet recruitingNCT07525271Not applicable
- Stress and Pain in People Living With HIVRecruitingNCT06784908Not applicable
- PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyRecruitingNCT06713616Phase 3
- Open-Label Psilocybin Study in Transdiagnostic PopulationRecruitingNCT06442423Phase 1
- Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of LifeRecruitingNCT05810259Not applicable
- Using Virtual Reality to Control the Audio-visual Inputs During Ketamine/Esketamine TreatmentCompletedNCT06139016Not applicableResults posted
- Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse PreventionCompletedNCT04760652Not applicableResults posted
- A Trial of Online LGBTQ-affirmative Cognitive Behavioral Therapy to Reduce Depression and Associated Health Risks Among Young AdultsCompletedNCT04408469Not applicableResults posted
- Ketamine for Severe Adolescent Depression: Intermediate-term Safety and EfficacyTerminatedNCT03889756Phase 2/3Results posted
- Insomnia Self-Management in Heart FailureCompletedNCT02660385Not applicableResults posted
- Ketamine Infusion for Adolescent Depression and AnxietyCompletedNCT02579928Phase 4Results posted
- Examining the Impact of Sirolimus on Ketamine's Antidepressant EffectsCompletedNCT02487485Phase 2Results posted
- New Haven MOMS PartnershipCompletedNCT01665872Not applicableResults posted
- Efficacy and Tolerability of Riluzole in Treatment Resistant DepressionCompletedNCT01204918Phase 2Results posted
- Levetiracetam in the Management of Bipolar DepressionCompletedNCT00566150Not applicableResults posted
- Ceftriaxone in the Management of Bipolar DepressionTerminatedNCT00566111Not applicableResults posted
- Mecamylamine for the Treatment of Patients With Depression and Alcohol DependenceCompletedNCT00563797Phase 3Results posted
- Naltrexone & SSRI in Alcoholics With Depression/PTSDCompletedNCT00338962Phase 3Results posted
- Long Term Follow Up KET-PDCompletedNCT06164756
- Adolescent Depression: Video Ads on InstagramCompletedNCT05755165Not applicable
- Single-Session Web-Based Training in Self-CompassionCompletedNCT05715034Not applicable
- Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)CompletedNCT05377840Not applicable
- Compassion Training and Mindfulness Training for Social Well-Being and Mental HealthCompletedNCT05227794Not applicable
- Single-Session Intervention Targeting Emotional Awareness, Clarity, and Acceptance to Reduce Depression/AnxietyCompletedNCT05109507Not applicable
- Reducing Transphobia Among Adolescents Through a Brief Video InterventionCompletedNCT04969003Not applicable
- Feasibility and Efficacy of a Digital Neurotherapy Protocol for Management of Depression, Cognition, and Quality of Life in Cancer SurvivorsCompletedNCT04961047Not applicable
- Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the CommunityCompletedNCT04947475Not applicable
- Ketamine for the Treatment of Depression in Parkinson's DiseaseCompletedNCT04944017Phase 2
- Reducing Depression-related Stigma and Increasing-treatment Seeking Among Black AdolescentsCompletedNCT04890990Not applicable
- Fixed Order, Open-Label, Dose-Escalation Study of DMT in HumansActive, not recruitingNCT04711915Phase 1
- Computer Presented and Physical Exercises to Maintain Cognitive Function and Emotional Health in Older AdultsCompletedNCT04404621Not applicable
- Detection of Postoperative Respiratory Depression in High Risk Patients Utilizing Minute Ventilation MonitoringCompletedNCT04017702
- Imaging mGluR5 and Synaptic Density in Psychiatric DisordersCompletedNCT03898297
- Intervention to Reduce Diaper Need and Increase Use of Pediatric Preventive CareCompletedNCT03490045Not applicable
- Integrating HIV and Depression Self-Care to Improve Adherence in Perinatal WomenCompletedNCT03016546Not applicable
- Imaging SV2A in Mood DisordersActive, not recruitingNCT02734602Not applicable
- Examination of Glutamate and mGluR5 in Psychiatric DisordersCompletedNCT02727972
- MOMS Hubs- CT Dept of Social Services Block GrantTerminatedNCT02459925Not applicable
- Preventing & Treating HIV Comorbidities in India: Multi-tiered Strategy for WomenCompletedNCT02319330Not applicable
- Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous KetamineCompletedNCT02289248Phase 1
- Computerized Cognitive Behavioral Therapy and Electroconvulsive TherapyCompletedNCT02176473Not applicable
- Examining The Effect Of Ketamine On Glutamate/Glutamine CyclingCompletedNCT02037035Early Phase 1
- Intracranial Atherosclerosis and Depression After Coronary Artery Bypass GraftCompletedNCT01838356
- Trial of Ketamine and Lithium Therapy in Bipolar DepressionWithdrawnNCT01768767Phase 2
- Ketamine for Depression and Alcohol DependenceCompletedNCT01551329Phase 1
- Ketamine for Low Mood States in the ERCompletedNCT01209845Phase 1
- Cortical GABA Concentrations in InsomniaCompletedNCT00765752
- Duloxetine for the Treatment of Postpartum DepressionWithdrawnNCT00617045Not applicable
- Vascular Effects of Sertraline in Heart FailureTerminatedNCT00585455
- Nicotinic Receptor Augmentation of SSRI AntidepressantsCompletedNCT00319319Phase 2